Roche Access for Patients (RAP) Program: Expanding Access to Cancer Treatments

Company Name:
Roche (Philippines) Inc.

Year Started:
October 2011

Target Conditions:
The RAP program is designed to support patients battling various cancers, including breast cancer, colorectal cancer, lung cancer, Non-Hodgkin’s lymphoma, and ovarian cancer.

Who Is Eligible?
The program is available to patients prescribed with Roche Oncology Brands: trastuzumab, rituximab, erlotinib, and bevacizumab.

About the RAP Program

The Roche Access for Patients (RAP) program is a dedicated initiative to make life-saving cancer treatments more accessible and affordable. It helps patients navigate the high costs of cancer therapy through financial assistance and logistical support.

Key features of the program include:

  1. Tiered Pricing and Discounts. Discounts are offered on prescribed treatments based on the patient’s economic class, ensuring fair and equitable access.
  2. Enrollment Through Physicians. Patients can enroll in the program through their attending medical oncologist, who will guide them through the process.
  3. Credit Investigation. A credit investigation component (CIBI) is included to determine eligibility for tiered pricing, ensuring assistance is directed to those in need.
  4. Call Center Support. A dedicated helpdesk provides clear instructions and support, helping patients and families navigate the program requirements with ease.
  5. Discount Availment. Patients can avail of discounted treatments through accredited sub-distributors or hospitals, simplifying the process of obtaining prescribed medications.

How to Access the Program

Patients interested in enrolling in the RAP program should consult a medical oncologist, who can assess their condition, recommend the appropriate Roche oncology treatment, and facilitate program enrollment.

Contact Information

For inquiries or assistance regarding the RAP program, patients or their families can contact:

  • Phone: (02) 718-7640

Why Programs Like RAP Matter

Cancer treatment is often associated with significant financial and emotional challenges. Programs like Roche Access for Patients (RAP) provide a lifeline by reducing costs and offering logistical support, allowing patients to focus on their recovery.

If you or a loved one is undergoing cancer treatment and prescribed one of Roche’s oncology medications, consider exploring the RAP program to ease the burden and access quality care.